Logourl black
From our private database of 14,100+ case briefs...

Merck KGaA v. Integra Lifesciences I, LTD

United States Supreme Court
545 U.S. 193 (2005)


Facts

Integra Lifesciences I, Ltd., and the Burnham Institute (collectively “Integra”) (plaintiff) held five patents related to the tripeptide sequence (Arg-Gly-Asp) known as the “RGD peptide,” which promoted cell adhesion. Merck KGaA (“Merck”) (defendant) provided funding to Dr. David Cheresh to conduct research at the Scripps Research Institute related to angiogenesis, the process by which new blood vessels sprout from existing vessels involved in many diseases. Cheresh successfully used RGD peptides provided by Merck in advancing the research. Integra filed suit in the U.S. District Court for the Southern District of California alleging patent infringement and inducement to infringe. Merck responded that it did not infringe Integra’s patents because it had used them in the course of research which was a covered exemption under 35 U.S.C. § 271(e)(1). A jury found that Merck infringed Integra’s patents and awarded damages. On appeal, a divided panel of the Court of Appeals for the Federal Circuit affirmed the district court’s judgment that Merck was not covered by the § 271(e)(1) exemption, and reversed on other issues. Merck’s petition for writ of certiorari was granted.

Rule of Law

The rule of law is the black letter law upon which the court rested its decision.

To access this section, please start your free trial or log in.

Issue

The issue section includes the dispositive legal issue in the case phrased as a question.

To access this section, please start your free trial or log in.

Holding and Reasoning (Scalia, J.)

The holding and reasoning section includes:

  • A "yes" or "no" answer to the question framed in the issue section;
  • A summary of the majority or plurality opinion, using the CREAC method; and
  • The procedural disposition (e.g. reversed and remanded, affirmed, etc.).

To access this section, please start your free trial or log in.

What to do next…

  1. Unlock this case brief with a free (no-commitment) trial membership of Quimbee.

    You’ll be in good company: Quimbee is one of the most widely used and trusted sites for law students, serving more than 97,000 law students since 2011. Some law schools—such as Yale, Vanderbilt, Berkeley, and the University of Illinois—even subscribe directly to Quimbee for all their law students. Read our student testimonials.

  2. Learn more about Quimbee’s unique (and proven) approach to achieving great grades at law school.

    Quimbee is a company hell-bent on one thing: helping you get an “A” in every course you take in law school, so you can graduate at the top of your class and get a high-paying law job. We’re not just a study aid for law students; we’re the study aid for law students. Read more about Quimbee.

Here's why 221,000 law students have relied on our case briefs:

  • Written by law professors and practitioners, not other law students. 14,100 briefs, keyed to 189 casebooks. Top-notch customer support.
  • The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
  • Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
  • Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.